Saptagir Labs, Jubilant Generics join hands to manufacture Remdesivir MD Bureau15 Sept 2020 1:00 PM ISTRemdesivir is an experimental antiviral drug developed by Gilead Sciences, Inc. as a course of treatment for COVID-19.
Saptagir Labs, Jubilant Generics join hands to manufacture Remdesivir MD Bureau14 Sept 2020 1:22 PM ISTRemdesivir is an experimental antiviral drug developed by Gilead Sciences, Inc. as a course of treatment for COVID-19.
Dr Reddys unveils COVID-19 drug Remdesivir under brand name Redyx in India Medical Dialogues Bureau10 Sept 2020 2:16 PM IST"Dr Reddy's Redyx is available in the strength of 100 mg vial," dr Reddy's said.
Rajasthan spells out rates to be charged at private hospitals for COVID treatment MD Bureau8 Sept 2020 12:49 PM ISTRajasthan: Establishing clarity on the protocol for Covid-19 treatment, the Rajasthan government has come up with revised rates to be charged from...
Researchers step up efforts to develop effective Covid-19 vaccine in US MD Bureau2 Sept 2020 11:30 AM ISTWashington: Researchers across the US have stepped up efforts towards the development of an effective Covid-19 vaccine, as another vaccine...
Indian-origin scientist uses AI to find COVID-19 drug candidates Ruchika Sharma16 Aug 2020 9:30 AM ISTNew Delhi: A team led by an Indian-origin scientist has used artificial intelligence (AI) to identify hundreds of new potential drugs that could...
Covid-19: Zydus Cadila unveils Remdesivir under brand name Remdac for Rs 2800 per vial in India Farhat Nasim13 Aug 2020 5:05 PM ISTZydus Cadila said Remdac will be made available across India through the group's distribution chain reaching out to government and private hospitals...
COVID-19 Battle: Everest Organics develops Remdesivir API Ruchika Sharma12 Aug 2020 1:24 PM ISTMumbai: Pharma major, Everest Organics on Monday said that Remdesivir API has been successfully developed in the R & D facility of the...
Pfizer teams up with Gilead to help manufacture Covid drug remdesivir Ruchika Sharma10 Aug 2020 12:38 PM ISTUS: Pfizer Inc (PFE.N) said on Friday it signed a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc...
Jubilant Life Sciences launches remdesivir under brand name JUBI-R in India Ruchika Sharma4 Aug 2020 1:00 PM ISTNoida: Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, has announced that its...
AbbVie, Amgen, Takeda Pharma launch joint trial of coronavirus medicines Ruchika Sharma4 Aug 2020 10:45 AM ISTUS: Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly...
Experts make weak recommendation for remdesivir in severe COVID-19 Dr. Kamal Kant Kohli31 July 2020 5:45 PM ISTA panel of international experts make a weak recommendation for the use of remdesivir in patients with severe covid-19, and strongly support continued...
